Evidence map›Paper›PMID 41940112›Full record

ArticleClinical optometry2026

An Observational, Multicenter, Parallel-Cohort Study Evaluating the Association of Clinical Manifestations and Patient-Reported Outcomes in Patients with

Bridgitte Shen Lee, Nicole Fram, Ruth Lapid-Gortzak, Marc Bloomenstein, Kayla Karpuk, Aimée Rosann-Peck Edell, Julio Echegoyen, Myhanh Nguyen, Kavita Dhamdhere, Elizabeth Yeu and 1 more

Abstract read
In one paragraph

Article in Clinical optometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bridgitte Shen LeeVision Optique, Houston, TX, USA.ORCID 0000-0002-1354-9401
Nicole FramAdvanced Vision Care, Los Angeles, CA, USA.
Ruth Lapid-GortzakOphthalmology, Amsterdam UMC, Amsterdam, the Netherlands.ORCID 0000-0002-6105-4235
Marc BloomensteinSchwartz Laser Eye Center, Scottsdale, AZ, USA.
Kayla KarpukVance Thompson Vision, Sioux Falls, SD, USA.
Aimée Rosann-Peck EdellEast Bay Eye Centers, San Ramon, CA, USA.
Julio EchegoyenGordon Schanzlin New Vision Institute, La Jolla, CA, USA.
Myhanh NguyenTarsus Pharmaceuticals, Inc, Irvine, CA, USA.
Kavita DhamdhereTarsus Pharmaceuticals, Inc, Irvine, CA, USA.
Elizabeth YeuTarsus Pharmaceuticals, Inc, Irvine, CA, USA.
Preeya K GuptaTriangle Eye Consultants, Raleigh, NC, USA.ORCID 0000-0003-0895-7870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to evaluate the clinical manifestations and patient-reported outcomes related to Patients and Methods: In this observational, multicenter, cross-sectional, parallel-cohort study conducted at 7 sites in the United States, adult participants were assigned to study cohorts based on collarette grade: Control Cohort (no collarettes), Cohort 1 (1-10 collarettes), or Cohort 2 (>10 collarettes). Key outcome measures included collarette grading, lid margin erythema, ocular symptoms (itching, fluctuating vision, irritation, redness, and burning) measured on a visual analog scale (VAS), and the location of ocular itching when present. Results: A total of 147 participants were enrolled and completed the study: 47 in the Control Cohort, 46 in Cohort 1, and 54 in Cohort 2 (a total of 100 participants with ≥1 collarette, identified as having Conclusion: This study demonstrated the vast majority (85%) of patients with

Indexed as

blepharitiscollarettesDemodexfluctuating visionocular symptomspatient-reported outcomesvisual analog scale

Identifiers

PMID41940112
PMCPMC13047913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.